Bibliography
The CPRD bibliography is updated on a quarterly basis (last update, December 2012).
If you have published papers using the CPRD which are not included in this list, please contact us at so that we can update the bibliography.
Abstract & Posters
Select the year to view the Abstracts & Posters
Abstract & Posters - 2011
- Statin Prescribing Following an Acute Coronary Syndrome: Are the NICE Guidelines Being Followed?
Boggon R, Eaton S, Timmis A, Hemingway H, Gabriel Z, Minhas I, van Staa T
Pharmacoepidemiology and Drug Safety, 2011; 20: S20 - Use of Thiazolidinediones and Risk of Osteoporotic Fracture: Disease or Drugs?
Bazelier M, Gallagher A, van Staa T, Cooper C, Leufkens H, Vestergaard P and De Vries F.
Pharmacoepidemiology and Drug Safety, 2011; 20: S26 - Creating a Mother Baby Link and Pregnancy Register for a UK Population
Boggon R, Gallagher A, Williams T, van Staa T
Pharmacoepidemiology and Drug Safety, 2011; 20: S44 - Use of Thiazolidinediones and Risk of Osteoporotic Fracture: The Danish National Databases
Bazelier M, Gallagher A, van Staa T, Cooper C, Leufkens H, Vestergaard P
Pharmacoepidemiology and Drug Safety, 2011; 20: S119 - Risk of Fracture in Patients with Myasthenia Gravis
Bazelier M, Pouwels S, Javaid K, Cooper C, Hilton-Jones D, Verschuuren J, van Staa T, De Vries F.
Pharmacoepidemiology and Drug Safety, 2011; 20: S119 - Cancer Recording and Mortality in the General Practice Research Database and Linked Cancer Registry, Hospital and Death Certificate Data
Boggon R, Moller H, Gallagher A, Leufkens H, Hammad T, Zhang H, van Staa T
Pharmacoepidemiology and Drug Safety, 2011; 20: S162 - STAtin-Induced Muscle Toxicity: Exploration Using the UK General Practice Research Database -Recruitment
Campbell J, van Staa TP, McCann G, O’Meara H, Pirmohamed M.
Pharmacoepidemiology and Drug Safety, 2011; 20: S183 - Linkage of the General Practice Research Database (GPRD) with Other Data Sources
Gallagher AM, Puri S, van Staa TP.
Pharmacoepidemiology and Drug Safety, 2011; 20: S230 - The Risk of Cancer Associated with Angiotensin-II Receptor Blockers
Bhaskaran K, Douglas I, Evans S, van Staa T, Smeeth L.
Pharmacoepidemiology and Drug Safety, 2011; 20: S279 - Assessment of Long-Term Adverse Drug Reactions, Regulatory Needs and Methodological Challenges
Duijnhoven RG, Straus SMJM, van Staa TP, Moride Y, Grimaldi LM, De Bruin ML
Pharmacoepidemiology and Drug Safety, 2011; 20: S368
Abstract & Posters - 2010
- Hip/Knee Arthroplasty and Risk of Hip Fracture: A Population-Based Case-Control Study
Lalmohamed A, Arden N, van Staa TP, Leufkens HGM, de Vries F.
Pharmacoepidemiology and Drug Safety, 2010; 19: S27 - Recruitment Strategy for Genetic Data Collection: The UK General Practice Research Database
Setakis E, de Vries F, Pirmohamed M, van Staa TP
Pharmacoepidemiology and Drug Safety, 2010; 19: S37 - Linking UK Death Certificate Data to UK Primary Care Data (GPRD) To Obtain Cause of Death
Setakis E, Gallagher A, Williams TW, van Staa TP
Pharmacoepidemiology and Drug Safety, 2010; 19: S83 - Use of Antidepressant Drugs and Risk ofOsteoporotic and Non-Osteoporotic Fractures: Focus on the Affinity for the Serotonin Receptor
Verdel BM, Souverein PC, Egberts TC, van Staa TP, Leufkens HGM, de Vries F.
Pharmacoepidemiology and Drug Safety, 2010; 19: S121 - Risk of Fracture in Patients with Multiple Sclerosis:The General Practice Research Database
Bazelier M, van Staa TO, Leufkens H, Vestergaard P, de Vries F.
Pharmacoepidemiology and Drug Safety, 2010; 19: S129 - Characterics of Exposure to Non-Steroid Anti-Inflammatory Drugs in European Databases
de Vries F, Kieler H, van Dijk L, Svensson T, van Staa TP
Pharmacoepidemiology and Drug Safety, 2010; 19: S174 - Linking Primary Care Data (UK GPRD) to Hospital Records (HES)
Eaton S, Setakis E, Williams TW, van Staa TP
Pharmacoepidemiology and Drug Safety, 2010; 19: S195 - Change in Drug Utilization Patterns in Statin Users with Increased Creatine Phosphokinase (CPK) Levels
de Vries F, Setakis E, van Staa TP
Pharmacoepidemiology and Drug Safety, 2010; 19: S206 - Risk of Cataract in Patients with Multiple Sclerosis: A Population-Based Cohort Study
S Mu¨ ller-Schotte, M Bazelier, van Staa TP, Leufkens HGM, de Vries F
Pharmacoepidemiology and Drug Safety, 2010; 19: S259 - Cause of Death in Patients with Multiple Sclerosis and Controls: The General Practice Research Database
Lalmohamed A, Bazelier MT, van Staa TP
Pharmacoepidemiology and Drug Safety, 2010; 19: S276 - Linking UK Death Certificate Data to UK Primary Care Data (General Practice Research Database)
Setakis E., Puri S, Gallagher A, Eaton S, De Vries F, Williams TW, van Staa TP. GPRD,
Pharmacoepidemiology and Drug Safety, 2010; 19: S310 - Representativeness of Subset of the General Practice Research Database (GPRD) Linked to Other Data Sources
Setakis E., Puri S, Williams TW.
Pharmacoepidemiology and Drug Safety, 2010; 19: S311
Abstract & Posters - 2009
- Prior Event Ratio Adjustment: A magic bullet or more of the same?
Gallagher A, MSC, deVries Frank, PhD and vanStaa Tjeerd
Pharmacepidemiology Drug Safety 2009:18;S1-S273.032 - Outcomes following a hip fracture and length of hospitalisation: the General Practice Database.
Gallagher A, deVries Frank, Ariely Rinat, vanStaa Tjeerd. - Long-Acting-beta2-agonists in Audit asthma and the pattern of risk of death and severe asthma outcomes: A study with the UK General Practice Database (GPRD)
Zhang Bill, DeVries Frank, Setakis Efrosini, VanStaa Tjeerd.
Pharmaco Drug Safety 2009: 18;S1-S273:594 - Initiation and persistence of warfarin or aspirin treatments in chronic atrial fibrillation: do the appropriatre patients receive stroke prophylaxis?
Gallagher A, Rietbrock S, Plumb J, VanStaa T. - How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? An analysis of the General Practice Database.
Gallagher A, Rietbrock S, Plumb J, VanStaa T. - Chronic atrial fibrillation: incidence, Prevalence and prediction of stroke using the CHAD2 Risk stratification scheme.
Gallagher AM, Rietbrock S, Heeley E, Plumb J, VanStaa T. - The contribution and persistence and compliance with bisphosphonates on fracture outcomes.
Rietbrock S, Olsen M, VanStaa TP. - Benefit harm modelling: what is this and what can it contribute to pharmacovigilance?
VanStaa T, Lynd LD, Leufkens Hubert GM, Raine J, Petri H. - The pattern of risk of myocardial infarction in ptients taking asthma medication: A study with UK General Practice Database
Zhang B, DeVries F, Setakis E Vanstaa TP
Pharmaco Drug Safety 2009:18;S1-S273:481 - Assessment of Data Quality in Health Care Databases
Juszczak, Williams T, VanStaa T,
Pharmaco Drug Safety 2009:18::S1-S273:422 - Use of Dopaminergic Drugs and risk of hip or femur fracture: A population case-control study.
Arbouw M, Movig K, Vanstaa T, deVries F et.a.
Pharmaco Drug Safety 2009:18::S1-S273:464 - Methodological and Regulatory challenges in the Assessment of long term drug safety
De Bruin ML, VanStaa TP, et al.
Pharmaco Drug Safety 2009:18::S1-S273:397 - Evaluation of the level of anticoagulation control in patients with non-valvular atrial fibrillation
Zhang,B, Setakis E, vanStaa TP
Pharmaco Drug Safety 2009:18::S1-S273:265 - Use of proton pump inhibitors and risk of hip fracture
Lalmohamed A, Pouwels S, Cooper C, VanStaa T, deVriesF, Leufkens B
Pharmaco Drug Safety 2009:18::S1-S273:039 - Use of Organic nitrates and the risk of hip fracture: A population based case-control study
Lalmohamed A, Pouwels S, Cooper C, VanStaa T, deVriesF, Leufkens B, et al
Pharmaco Drug Safety 2009:18::S1-S273:018 - Risks of mortality and stroke associated with sub-optimally anticoagulated atrial fibrillation patients
Setakis E, Zhang B, VanStaa TP
Pharmaco Drug Safety 2009:18::S1-S273:509 - Insomnia as a predictor of depression in UK primary care
de Vries F: Gallagher AM; Lader MH; Tylee AT; Donoghue J; Cockle SM; vanStaa TP, Nutt DJ.
European Neuropsychopharmacology 2009(19)S372-S373 - Resource use in depressed patients with sleep disturbance
Gallagher, AM; deVries F; Nutt DJ; Donoghue J; Tylee AT, Cockle SM; vanStaa TP; Lader MH.
European Neuropsychopharmacology 2009(19)S 378-S379 - Initiation of hypnotics or anxiolytics in depressed patients with sleep disturbance
Gallagher, AM; deVries F; Nutt DJ; Donoghue J; Tylee AT, Cockle SM; vanStaa TP; Lader MH.
European Neuropsychopharmacology 2009(19)S379 - The risk of suicide and suicidal ideation in depressed patiens with sleep disturbance.
Gallagher, AM; deVries F; Nutt DJ; Donoghue J; Tylee AT, Cockle SM; vanStaa TP; Lader MH.
European Neuropsychopharmacology 2009(19)S380 - Persistance with hypnotics in depressed patients treated in UK primary care.
Gallagher, AM; deVries F; Nutt DJ; Donoghue J; Tylee AT, Cockle SM; vanStaa TP; Lader MH.
European Neuropsychopharmacology 2009(19)S381
Abstract & Posters - 2008
- Outcomes following a hip fracture and length of hospitalization
De Vries F, Gallagher A, Ariely R, van Staa T.
Pharmo - Last menstrual period estimation techniques compared to physician recorded last menstrual period dates in the GPRD.
Devine ST, Hammad TA.
Pharmacoepidemiology & Drug Safety:2008;17:S228 - GPRD Study of pregnancy outcomes following the prescribing of DMARDs.
Vroom F, Snowball J, McGrogan A, de Jong-van Berg L, deVries C.
Pharmacoepidemiology & Drug Safety:2008;17:S227 - Changes in the characteristics of patients prescribed selective Cox-2 inhibitors after the 2004 withdrawal of Rofecoxib.
Setakis E, Leufkens HGM, vanStaa T.
Pharmacoepidemiology & Drug Safety:2008;17:S9 - The feasibility of linking the English Hospital Episode Statistics to the GPRD.
Eaton SC, Williams TJ, Puri S, vanStaa T.
Pharmacoepidemiology & Drug Safety:2008;17:S214 - Benefit-Harm Modelling: What is this and what can it contribute to Pharmacovigilance?
Van Staa TP, Lynd LD, Leufkens GM, Raine J, Petri H. - Effect of antibiotics for Otitis Media on mastoiditis in children: Retrospective Cohort Study using the UK GPRD.
Thompson PL, Gilbert R, Long P, Saxena S, Sharland M, Wong I.
Pharmacoepidemiology & Drug Safety:2008;17:S209 - Mortality following antiepileptic drugs in paediatrics with epilepsy – preliminary results using the GPRD.
Ackers R, Besag FMC, Wong ICK,
Pharmacoepidemiology & Drug Safety:2008;17:S9 - Outcomes evaluation following 12 month treatment with once daily tiotropium compared with four times daily Ipratropium/salbutamol: A GPRD study on patients with COPD.
Griffin J. Lee S, Caiado M, Price D, Kesten S
Pharmacoepidemiology & Drug Safety:2008;17:S183 - A review of Post-Marketing safety studies submitted to the UK Regulator from 1993-2005
Shafe ACE, Wise L, Waller P.
Pharmacoepidemiology & Drug Safety:2008;17:S179 - An analysis of glitazone use and small bone fractures using the GPRD database
Irvine D, Wise L.
Pharmacoepidemiology & Drug Safety:2008;17:S174 - Association between Alendronate Usage and Vitreous detachment: A cohort study.
Shafe A CE, Wise L.
Pharmacoepidemiology & Drug Safety:2008;17:S165 - The General Practice Research Database as a pregnancy registry system: Anticonvulsants as an example.
Charlton R, Weil J, Cunnington M, deVries C.
Pharmacoepidemiology & Drug Safety:2008;17:S159 - Fracture risk in patients receiving concomitant bisphosphonate and proton pump inhibitors or bisphosphonates alone: The UK General Practice Research Database.
deVries F, Cooper A, Logan R, Cockle S, Cooper C, VanStaa TP.
Pharmacoepidemiology & Drug Safety:2008;17:S151 - Validation of pregnancy identification algorithm within the GPRD.
Devine ST, Hammad TA, Andrews EB.
Pharmacoepidemiology & Drug Safety:2008;17:S126 - Diagnostic codes for sudden cardiac death and ventricular arrhythmia functioned poorly to identify outpatient events in the GPRD.
Hennessy S, Leonard CE, Palumbo CM, Bilker WB, Newcomb C, Kimmell S.
Pharmacoepidemiology & Drug Safety:2008;17:S86 - The contribution of persistence and compliance with bisphosphonates on fracture outcomes.
Reitbrock S, Olson M, Vanstaa TP
Pharmacoepidemiology & Drug Safety:2008;17:S78 - Chronic atrial fibrillation: Incidence, Prevalence and prediction of stroke using the CHADS2 risk stratification scheme.
Gallagher, AM, Reitbrock S, Heeley E, Plumb J, Vanstaa TP.
Pharmacoepidemiology & Drug Safety:2008;17:S31 - Exploring channelling bias of anti-epileptic drugs in epilepsy patients in a US claims database and a UK General Practice database.
Ishihara-Paul L, Webb DJ, Juneja M, Kanakarja P, Weil J.
Pharmacoepidemiology & Drug Safety:2008;17:S23 - Initiation and persistence of warfarin or aspirin treatments in chronic atrial fibrillation: Do the appropriate patients receive stroke prophylaxis?
Gallagher AM, Reitbrock S, Plumb J, VanStaa TP.
Pharmacoepidemiology & Drug Safety:2008;17:S11
- Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
Vanstaa T, Reitbrock S, Setakis E.
Pharmacoepidemiology & Drug Safety:2008;17:S9 - Regional variations in joint replacement: disease or service provision?
Culliford D, Maskell J, Mullee M, Arden N.
British Society of Rheumatology (2008) - Temporal changes in the trends of total and unicondylar knee replacements in the UK.
Maskell J, Culliford D, Mullee M, Arden K.
British Society of Rheumatology (2008) - Antibiotic prescribing for otitis media in children in UK primary care: have the national guidelines affected GP prescribing practice?
Thompson, P.L., Gilbert, R., Long, P.F., Saxena, S., Sharland, M and Wong, I.C.K.
Pharmacoepidemiology and Drug Safety. 2008;17:S273. - Do antibiotics for otitis media reduce the risk of mastoiditis in children?
Thompson, P.L., Gilbert, R., Long, P., Saxena, S., Sharland, M and Wong, I.C.K.
Archives of Disease in Childhood. 2008;93:A75. - Do antibiotics for otitis media reduce the risk of mastoiditis in children?
Thompson, P.L., Gilbert, R., Long, P., Saxena, S., Sharland, M and Wong, I.C.K.
International Journal of Pharmacy Practice. 2008;16:A10. - Effect of antibiotics for otitis media on mastoiditis in children: A retrospective cohort study using the UK General Practice Research database.
Thompson, P.L., Gilbert, R., Long, P., Saxena, S., Sharland, M and Wong, I.C.K.
Pharmacoepidemiology and Drug Safety. 2008;17:748.
Abstract & Posters - 2007
- The effect of heart rate and it’s changes on cardiovascular disease and mortality.
Setakis E, Williams TJ, van Staa TP
Pharmacoepidemiology & Drug Safety (2007) - Onset and offset of fracture benefit associated with bisphosphonate use.
Gallagher AM, Rietbrock S, Olson M, Leufkens HGM, van Staa TP.
Pharmacoepidemiology & Drug Safety (2007) - The incidence of Wegener’s granulomatosis and Chrug Strauss syndrome in the UK General Practice Database
Watts R, Al-Taiar A, Skinner J, Scott D, MacGregor A.
American College of Rheumatology (2007) - What are antibiotics being prescribed for in children, and how has this changed over time in UK general practice?
Thompson, P.L., Gilbert, R., Long, P., Sharland, M. and Wong, I.C.K.
International Journal of Pharmacy Practice. 2007;15:A24. - Changes in antibiotic-resistance rates for invasive Haemophilus Influenzae isolates in England and Wales and their association with antibiotic prescribing in the community.
Ladhani, S., Heath, P., Ramsay, M., Thompson, P., Sharland, M. and Slack, M.
Archives of Disease in Childhood. 2007; 92:A80. - What are antibiotics being prescribed for in children, and how has this changed over time in UK general practice?
Thompson, P.L., Gilbert, R., Long, P., Sharland, M. and Wong, I.C.K.
Archives of Disease in Childhood. 2007;92:A86
Abstract & Posters - 2006
- Blood pressure lowering thresholds and stroke
Qizilbash N, Mander A, Feudjo-Tepie M, Boudiaf N.
Pharmacoepidemiology & Drug Safety (2006); 15: S271 - A time-trend analysis of all clinical activity, amoxicillin/co-amoxiclav prescribing, acute otitis media and acute mastoiditis in paediatrics in general practice.
Thompson, P.L., Gilbert, R., Long, P., Murray. M.L., Sharland, M. and Wong, I.C.K.
Pharmacoepidemiology and Drug Safety. 2006;15:S147-S148
Abstract & Posters - 2005
- Use of the General Practice Research Database to detect drug-induced autoimmune disease.
Schoonen WM, Somers EC, Hall AJ
Pharmacoepidemiology & Drug Safety (2005); 14: S199 - A reanalysis of two studies that reported contrasting results on the association between statin use and risk of fracture in the same database.
De Vries F, de Vries C, Cooper C, Leufkens H, van Staa TP
Pharmacoepidemiology & Drug Safety (2005); 14: S199 - Use of antiepileptic drugs and risk of fractures: a case-control study among patients with epilepsy.
Souverein PC, Webb DJ, Weil J, van Staa TP, Egberts TCG
Pharmacoepidemiology & Drug Safety (2005); 14: S192-193 - Rates of serious vascular events among patients dispensed type 2 antidiabetic medications in the U.S. and U.K.
Velentgas P, Cole JA, Costa L, Ziyadeh N, Shea K, Seeger JD, Walker AM
Pharmacoepidemiology & Drug Safety (2005); 14: S173-174 - The risk of venous thromoboembolism associated with cyproterone acetate amongst men with advanced carcinoma of the prostate.
Seaman H, Farmer RDT
Pharmacoepidemiology & Drug Safety (2005); 14: S172 - Matched retrospective cohort study of breast cancer incidence among initiators of racemic zopiclone, temazepam, and zolpidem in the General Practice Research Database.
Eng PM, Ziyadeh N, Nordstrom BL, Caron J, Amato D, Seeger JD
Pharmacoepidemiology & Drug Safety (2005); 14: S162 - Changes in the prevalence and incidence of coronary heart disease in the UK between 1992 and 2001.
Seaman H, Hutchinson A, Farmer RDT, de Vries CS
Pharmacoepidemiology & Drug Safety (2005); 14: S155-156 - Characteristics of end stage renal disease patients receiving phosphate binder therapy in UK primary care.
Gallagher AM, Elgazzar H, Hughes G
Pharmacoepidemiology & Drug Safety (2005); 14: S145-146 - A novel methodology for measuring the influence of comorbidity in disease outcome studies.
Kiri VA, Visik G, Muellerova H, MacKenzie G
Pharmacoepidemiology & Drug Safety (2005); 14: S135-136 - Risk of fracture in patients using high-dose intermittent oral glucocorticoids.
De Vries F, van Staa TP, Bracke M, Cooper C, Lammers JW, Leufkens H
Pharmacoepidemiology & Drug Safety (2005); 14: S133-134 - The association between antiepileptic drug use and aplastic anaemia.
Van den Bemt PMLA, Souverein PC, van Staa TP, Meyboom RHB, van Solinge WW, Egberts TCG, Leufkens BGM
Pharmacoepidemiology & Drug Safety (2005); 14: S109 - Tranexamic acid, menorrhagia, and venous thromoboembolism: a case-control study using the GPRD.
Sundstrom A, Seaman H, Alfredsson L
Pharmacoepidemiology & Drug Safety (2005); 14: S108 - Risk factors for inflammatory bowel disease in the general population.
Garcia Rodriguez LA, Gonzalez-Perez A, Johansson S, Wallander MA
Pharmacoepidemiology & Drug Safety (2005); 14: S99-100 - Evaluation of prescribing to patients with coronary heart disease against the national service framework.
Hutchinson A, Seaman H, Farmer R, de Vries C
Pharmacoepidemiology & Drug Safety (2005); 14: S85-86 - Pneumonia in an asthma cohort in general practice in the UK.
Garcia Rodriguez LA, Wallander MA, Johansson S, Ruigomez A
Pharmacoepidemiology & Drug Safety (2005); 14: S97-98 - Demyelinating disorders are more common among patients with inflammatory bowel disease (IBD) even in the absence of anti-TNFα therapy.
Gupta G, Gelfand JM, Lewis JD
Pharmacoepidemiology & Drug Safety (2005); 14: S66 - Propensity score matching to identify cohorts of patients prescribed type 2 diabetes medications in the General Practioner Research Database.
Cole JA, Velentgas P, Ziyadeh N, Costa L, Shea K, Seeger J, Walker AM
Pharmacoepidemiology & Drug Safety (2005); 14: S62 - Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population.
Huerta C, Varas Lorenzo C, Castellsague J, Garcia Rodriguez LA
Pharmacoepidemiology & Drug Safety (2005); 14: S59 - Depression and the underlying hazard of suicidal behavior.
Rietbrock S, Martinez C
Pharmacoepidemiology & Drug Safety (2005); 14: S55 - Trends in prescribing of methylphenidate in the UK.
Williams TJ, Hughes G, Martinez C
Pharmacoepidemiology & Drug Safety (2005); 14: S54-55
- Duration of therapy among patients dispensed type 2 diabetes medications in the U.S. and U.K.
Velentgas P, Cole JA, Ziyadeh N, Costa L, Shea K, Seeger JD, Walker AM
Pharmacoepidemiology & Drug Safety (2005); 14: S49 - Lymphoma risk in patients with rheumatoid arthritis who received 2 or more disease modifying antirheumatic drugs (DMARDs): a retrospective cohort study in the GPRD.
Mines DI, Novelli LA, Yu H
Pharmacoepidemiology & Drug Safety (2005); 14: S30 - New users of inhaled corticosteroids (ICS) in the United Kingdom have higher probability of continuous use than new users in the Netherlands.
Menckeberg TT, Pokladnikova J, Bouvy ML, Belitser SV, Bracke M, Raaijmakers JAM, Leufkens HGM
Pharmacoepidemiology & Drug Safety (2005); 14: S29 - Epidemiology and treatment patterns of psoriasis in the General Practice Research Database (GPRD).
Gelfand JM, Wang X, Liu Q, Neiman A, Weinstein R, Margolis DJ, Troxel AB
Pharmacoepidemiology & Drug Safety (2005); 14: S23-24 - Incidence of selected outcomes among matched cohorts of initiators of racemic zopiclone, temazepam, and zolpidem in the General Practice Research Database.
Eng PM, Ziyadeh N, Nordstrom BL, Caron J, Amato D, Seeger JD
Pharmacoepidemiology & Drug Safety (2005); 14: S22-23 - Use of beta-blockers and risk of hip and vertebral fracture: relationships to daily and cumulative dose.
De Vries F, Souverein PC, De Bruin ML, Leufkens HGM, Cooper C, Van Staa TP
Pharmacoepidemiology & Drug Safety (2005); 14: S21-22 - Prevalence of osteoarthritis and rheumatoid arthritis: cross-sectional analysis in a follow-up study.
Gonzalez-Perez A, Garcia Rodriguez LA, Johansson s, Wallander MA
Pharmacoepidemiology & Drug Safety (2005); 14: S7-8
Abstract & Posters - 2004
- The risk of first seizure associated with mefenamic acid in women of reproductive age
Mines DI, Novelli LA
Pharmacoepidemiology & Drug Safety (2004) 13: S333-4 - Natural history of dyspepsia in general practice: incidence, comorbidity and risk factors
Ruigomez A, Wallander MA, Johannson, Garcia Rodriquez LA
Pharmacoepidemiology & Drug Safety (2004) 13: S309 - Natural history of chest pain in general practice setting
Ruigomez A, Johansson S, Wallander MA, Garcia Rodriguez LA
Pharmacoepidemiology & Drug Safety (2004) 13: S308-9 - Estimating annual prevalence of clinically-significant psoriasis in the General Practice Research Database (GPRD)
Crane MM, Hastie JM, Black CL
Pharmacoepidemiology & Drug Safety (2004) 13: S306-7 - A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the UK
Cavazzoni P, Hornbuckle K, Carlson C, DeLisle F, Noel R, Breier A
Pharmacoepidemiology & Drug Safety (2004) 13: S304 - Increased rates of diagnosis for hypertension or dyslipidaemia in patients previously identified with one of these risk factors: data from the United Kingdom
MacDonald TM, Morant SV, Mozaffari E
Pharmacoepidemiology & Drug Safety (2004) 13: S302-3 - The risk of venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol - an update
Seaman HE, de Vries CS, Farmer RDT
Pharmacoepidemiology & Drug Safety (2004) 13: S275 - Cross-over cohort study of incident VTE in women exposed to cyproterone in UK primary care
Moseley JNS
Pharmacoepidemiology & Drug Safety (2004) 13: S274-5 - Treatment patterns for hypertension, dyslipidaemia, and both conditions in the United Kingdom: 1997-2001
MacDonald TM, Morant SV, Baker CL, Mozaffari E
Pharmacoepidemiology & Drug Safety (2004) 13: S237-8 - Systemic lupus erythematosus: calculating the prevalence of relapsing-remitting disease using left-censored data
Nightingale AL, de Vries CS, Farmer RDT
Pharmacoepidemiology & Drug Safety (2004) 13: S230 - Measuring incidence rates using GPRD: how soon after registration do incidence rates reach baseline levels?
Lewis JD, Bilker WB, Weinstein R, Strom BL
Pharmacoepidemiology & Drug Safety (2004) 13: S230-1 - Methodological issues in determining daily hormonal contraceptive exposure on the General Practice Research Database
Snowball JM, Farmer RDT
Pharmacoepidemiology & Drug Safety (2004) 13: S157-8 - Medications prescribed before and during early pregnancy in a cohort of 81 975 mother-baby pairs: a population based study using the automated data of the General Practice Research Database
Hardy JR, Leaderer BP, Holford TR, Hall GC, Bracken MB
Pharmacoepidemiology & Drug Safety (2004) 13: S138-9 - First use of oral contraceptives before and after the pill scare in the UK
Farmer RD, de Vries CS, Seaman HE
Pharmacoepidemiology & Drug Safety (2004) 13: S138 - Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation (AF) treated with warfarin
Gasse C, Hollowell J, Meier CR, Troost J, Schneider V, Haefeli WE
Pharmacoepidemiology & Drug Safety (2004) 13: S134-5 - Survival analysis to examine the risk of a recurrent stroke of patients in the General Practice Research Database
Short D, Chapman S
Pharmacoepidemiology & Drug Safety (2004) 13: S134 - The increasing proportion of patients with type 2 diabetes converting to insulin therapy in the UK
Mulnier H, Lovell D, Lawrenson R
Pharmacoepidemiology & Drug Safety (2004) 13: S129 - Predicting cardiac arrhythmias and sudden death among diabetic users of arrhythmogenic non-antiarrhythmic drugs
De Bruin ML, van Staa TP, Belitser SV, Leufkens HGM, Hoes AW
Pharmacoepidemiology & Drug Safety (2004) 13: S124 - In-utero exposure to antihistamines and the risk of congenital hypospadias or cryptorchidism in male births
Williams T, Hughes G, Martinez C
Pharmacoepidemiology & Drug Safety (2004) 13: S126 - Adverse drug reaction profiles for fluoxetine, paroextine and amitriptyline using data recorded by general practitioners in the United Kingdom (UK)
Davis S, Rietbrock S, Martinez C
Pharmacoepidemiology & Drug Safety (2004) 13: S118-9
- Treatment of high-risk hypertensive patients in the United Kingdom: 1997-2001
MacDonald TM, Morant SV, Baker CL, Mozaffari E
Pharmacoepidemiology & Drug Safety (2004) 13: S103 - Sudden unexpected death (SUDEP) in children and adolescents with epilepsy
Hsia Y, de Vries CS
Pharmacoepidemiology & Drug Safety (2004) 13: S83 - The risk of upper gastrointestinal tract bleeding associeated with mefenamic acid in women of reproductive age
Mines DI, Novelli LA
Pharmacoepidemiology & Drug Safety (2004) 13: S54-55 - The incidence of ventricular fibrillation and ventricular tachycardia in a primary care population
Hughes G, Rietbrock S, Reiter C, Martinez C
Pharmacoepidemiology & Drug Safety (2004) 13: S48 - A systematic approach for describing comorbidities using the UK General Practice Research Database
Roskell NS, Logie JW, Stender M, Feudjo-Tepie M
Pharmacoepidemiology & Drug Safety (2004) 13: S42 - An algorithm to extract medical codes for diagnoses from unstructured free text recorded by general practitioners in the UK
Shah AD, Martinez C
Pharmacoepidemiology & Drug Safety (2004) 13: S41-2 - Validity of the General Practice Research Database: a systematic review
Schoonen WM, Hall AJ
Pharmacoepidemiology & Drug Safety (2004) 13: S41 - Low treatment rates and poor goal attainment in patients with concomitant hypertension and dsylipidaemia: data from the United Kingdom
MacDonald TM, Morant SV, Baker CL, Mozaffari E
Pharmacoepidemiology & Drug Safety (2004) 13: S29-30 - Acute and long-term risk of femur fractures in patients on antipsychotics
Hugenholz GWK, Heerdink ER, Nolen WA, Egberts TCG
Pharmacoepidemiology & Drug Safety (2004) 13: S21-2 - Is there cross-reactivity between penicillins and cephalosporins? Investigaion of a large electronic medical record database.
Apter AJ, Kinman JL, Milker WB, Herlin M, Margolis DJ, Lautenbach E, Hennessy S, Strom BL
Pharmacoepidemiology & Drug Safety (2004) 13: S18 - The effect of selective serotonin reuptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression
Kimmel SE, Berlin JA, Oslin DW, Weinstein RB, Kinman JL, Sauer WH, Lewis JD
Pharmacoepidemiology & Drug Safety (2004) 13: S6 - Use of oral steroids and the risk of acute myocardial infarction in the U.K.
Varas-Lorenzo C, Garcia-Rodriguez LA, Maguire A, Perez-Gutthann S
Pharmacoepidemiology & Drug Safety (2004) 13: S5-6 - A comparison of the cause of death recorded in the General Practice Research Database with national mortality statistics in England and Wales
Shah AD, Martinez C
Pharmacoepidemiology & Drug Safety (2004) 13: S2-3
Abstract & Posters - 2003
- The 'Drug Allergy and Intolerance' Structured Data Area: an additional information source of suspected Adverse Drug Reactions (ADRs) in the Full Feature General Practice Research Database
Martinez C, Davis S, Heeley E, Moseley J, Rietbrock S.
Pharmacoepidemiol and Drug Safety (2003); 12: S244 - Auditing the quality of data in the General Practice Research Database
Davis S, Rietbrock S, Rubino A, Shah AD, Williams T, Martinez C.
Pharmacoepidemiol and Drug Safety (2003); 12: S61 - An algorithm to derive a numerical daily dose from text dosage instructions in the General Practice Research Database
Shah AD, Martinez C.
Pharmacoepidemiol and Drug Safety (2003); 12: S60-61
Abstract & Posters - 2002
- Linkage of Socio-Economic Status data to the General Practice Research Database
Williams TJ, Martinez C
Pharmacoepidemiology & Drug Safety (2002) 11: S168 - Validation of birth recording and development of a mother-baby link in the FF-GPRD
Rubino A
Pharmacoepidemiology & Drug Safety (2002) 11: S70-71